A recent study has demonstrated the power of metabolic engineering in enhancing the antitumor activity of chimeric antigen ...

Tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) exhibit significant metabolic dysregulation, ...

Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products, today announced upcoming presentations at the ...

Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in ...

Here’s a look at Tuesday’s business headlines with Jane King, who has the latest on Lilly’s acquisition of a biotech company ...

If you happen to keep up with Ford’s F-150, then you might have already been aware of complaints that have been circulating ...

Does your car need repairs? Check the latest recall list.

Austin police say a new high-tech auto theft trick is turning professional diagnostic tools into gear for stealing cars.

Tim Cook to step down as Apple CEO, Lori Chavez-DeRemer resigns, stocks dip and Eli Lilly announces major biotech acquisition ...

B for Kelonia adds a credible in vivo CAR-T platform aimed at multiple myeloma, with a one-time IV delivery and no ...

Across its lifespan, the Nissan Pathfinder has encountered a few issues you need to check if you're buying one.

Eli Lilly announced Monday that it is acquiring Kelonia Therapeutics, a developer of gene therapies with a particular focus ...